openPR Logo
Press release

In-Vitro Diagnostics Market is expected to reach US$ 90,656.80 Mn by 2027 With F. Hoffmann-la Roche Ltd.; Danaher; Abbott; Siemens AG; Sysmex Corporation; Thermo Fisher Scientific, Inc.; BD; Biomérieux SA; Bio-Rad Laboratories, INC.; and Qiagen

05-04-2021 05:01 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
In-Vitro Diagnostics Market

In-Vitro Diagnostics Market

According to The Insight Partners market research study titled “In-Vitro Diagnostics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product & Service, Technology, Application, and End User,” the global in-vitro diagnostics market is expected to reach US$ 90,656.80 million by 2027 from US$ 63,746.63 million in 2019. The market is estimated to grow at a CAGR of 4.5% from 2020 to 2027. The report highlights the trends prevalent in the global in-vitro diagnostics market and the factors driving the market along with those that act as deterrents to its growth.

For sample report click:  https://www.theinsightpartners.com/sample/TIPBT00002657/?openpr-10225

In terms of product & services, the in-vitro diagnostics market is segmented into instruments, reagents & kits, and software & services. In 2019, the reagents & kits segment held a largest market share of the in-vitro diagnostics market. This segment is also expected to dominate the market during the forecast period owing to increasing number of diagnostics tests and rising prevalence of chronic conditions. Moreover, the instruments segment is anticipated to witness considerable growth rate during the forecast period. Certain factors, such as developing healthcare infrastructure and growing demand for rapid disease diagnosis, are expected to drive the segment.

Increasing prevalence of chronic and infectious diseases, growing geriatric population, and rising demand for in-vitro diagnostics during COVID-19 pandemic are driving the market. However, the lack of healthcare infrastructure and reimbursement policies is likely to have a negative impact on the growth of the market in the coming years.

Prominent players operating in in-vitro diagnostics market include F. Hoffmann-la Roche Ltd.; Danaher; Abbott; Siemens AG; Sysmex Corporation; Thermo Fisher Scientific, Inc.; BD; Biomérieux SA; Bio-Rad Laboratories, INC.; and Qiagen. The market players are focused toward bringing new and innovative products to sustain their position in the market. For instance, in January 2021, Roche announced that it has launched two CE-IVD, which are its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer. It is likely to help in determining the best treatment strategy for each patient. The image analysis algorithms uses artificial intelligence to support pathologists in making faster, more accurate patient diagnoses in breast cancer.

The report segments the global in-vitro diagnostics market as follows:

By Product & Services

Reagents & Kits
Instruments
Software & Services
By Technology
Immunoassay/Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Blood Glucose Self-Monitoring
Coagulation & Hemostasis
Hematology
Urinalysis
Others

By Application

Infectious Diseases
Diabetes
Oncology
Cardiology
Autoimmune Diseases
Nephrology
Others

By End User

Hospitals
Laboratories
Homecare
Others
By Geography
North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
Japan
China
India
Australia
South Korea
Rest of APAC
Middle East & Africa (MEA)
South Africa
UAE
Saudi Arabia
Rest of MEA
South & Central America (SCAM)
Brazil
Argentina
Rest of SCAM

Interested in purchasing this Report?  Click here @ https://www.theinsightpartners.com/buy/TIPBT00002657/?openpr-10225

Contact Us:
The Insight Partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-Vitro Diagnostics Market is expected to reach US$ 90,656.80 Mn by 2027 With F. Hoffmann-la Roche Ltd.; Danaher; Abbott; Siemens AG; Sysmex Corporation; Thermo Fisher Scientific, Inc.; BD; Biomérieux SA; Bio-Rad Laboratories, INC.; and Qiagen here

News-ID: 2279754 • Views: 194

More Releases from The Insight Partners

Weather Monitoring System Market with COVID-19 Impact Analysis, Top Companies Ba …
Global Weather Monitoring System Market is expected to grow at a higher rate during the forecast period 2021-2027.The report includes the latest coverage of the impact of COVID-19 on the Weather Monitoring System Market. Weather monitoring system allows users to access weather data in real time from various locations within the mobile network's coverage area. These solutions collect weather data such as temperature, humidity, wind speed and direction, rain fall,
Bioreactors Market is expected to reach US$ 5,169.01 Mn by 2027 With Thermo Fish …
According to The Insight Partners market research study on "Bioreactors Market to 2027 – Global Analysis and Forecasts by Cell, Molecule, Technology, and End User". The global bioreactors market is expected to reach US$ 5,169.01 Mn by 2027 from US$ 2,958.50 Mn in 2019. The market is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report provides trends prevailing in the global bioreactors market and
Genome Editing Market is estimated to reach US$ 10,691.0 Mn by 2025 With Transpo …
According to The Insight Partners market research study titled ‘Genome Editing Market to 2025 - Global Analysis and Forecasts by Technology, Application and End User, the global genome editing market was valued at US$ 3,210.1 Mn in 2017 and is estimated to reach US$ 10,691.0 Mn by 2025. The report highlights the trends prevalent in the global genome editing market and the factors driving the market along with the restraints
Corrugated Packaging Software Industry 2021 Market Demand, Size, Growth, Trends, …
The growth in the adoption of corrugated boxes by e-commerce vendors is driving the growth of the corrugated packaging software market. However, the high initial cost may restrain the growth of the corrugated packaging software market. Furthermore, owing to the growing variety of goods bought online, the need for corrugated boxes are rising continuously, which is anticipated to witness massive demand during the forecast period. Get Sample PDF Brochure at –

All 5 Releases


More Releases for Diagnostics

Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test